Product Information

INVOKAMET XR 150-500 MG TABLET is a brand product labeled by Janssen Pharmaceuticals Inc., priced at $9.5612 per EA under NDC 50458094201. Its NADAC has been published 345 times since Aug 23, 2017.

INVOKAMET XR 150-500 MG TABLET

canagliflozin and metformin hydrochloride
$9.5612per EA

Strength

150; 500 mg/1; mg/1

NDC

50458094201

Classification

Brand

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Last Updated

6/17/2026

Approval Type

New Drug (NDA)

FDA Application

NDA205879

On Market Since

9/20/2016

Pharmacological Classes

Biguanide
Biguanides
P-Glycoprotein Inhibitors
Sodium-Glucose Cotransporter 2 Inhibitor
Sodium-Glucose Transporter 2 Inhibitors

Price Statistics

The NADAC for INVOKAMET XR 150-500 MG TABLET has been published 345 times since Aug 23, 2017, and over the history we have for it it has risen 39.8%. The table below summarizes its recorded NADAC range and movement.

Current price$9.5612 per EA
All-time high$9.6176 (Apr 16, 2025)
All-time low$6.8402 (Aug 23, 2017)
52-week high$9.5958
52-week low$9.5612
Median price$8.3252
Average price$8.5110
Largest weekly change+10.4% (Apr 17, 2024)
Weeks tracked345
Tracking sinceAug 23, 2017

Price History

1W

0.0%

1M

-0.1%

3M

-0.0%

6M

-0.1%

1Y

-0.3%

3Y

+10.1%

5Y

+10.1%

All

+39.8%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of INVOKAMET XR 150-500 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for INVOKAMET XR 150-500 MG TABLET, manufactured by Janssen Pharmaceuticals Inc., is $9.5612 per EA (NDC 50458094201), effective Jun 24, 2026.

How has the price of INVOKAMET XR 150-500 MG TABLET changed over time?

Over the history we have for it, the NADAC for INVOKAMET XR 150-500 MG TABLET has risen 39.8%. It has been tracked across 345 weekly CMS publications since Aug 23, 2017.

What are the highest and lowest recorded NADAC prices for INVOKAMET XR 150-500 MG TABLET?

Since Aug 23, 2017, the NADAC for INVOKAMET XR 150-500 MG TABLET has ranged from a low of $6.8402 (Aug 23, 2017) to a high of $9.6176 (Apr 16, 2025), with a median of $8.3252 per EA.

Are there cheaper alternatives to INVOKAMET XR 150-500 MG TABLET?

1 NADAC-published product shares the same active ingredient, strength, and dosage form as INVOKAMET XR 150-500 MG TABLET, but none are currently priced below it.

Who manufactures INVOKAMET XR 150-500 MG TABLET?

INVOKAMET XR 150-500 MG TABLET (NDC 50458094201) is labeled by Janssen Pharmaceuticals Inc., and CMS classifies it as a brand product.